InsidersTradesSigma
Follow the 美迪西 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 美迪西 has logged 5 reports. Market capitalisation: €14.4bn. The latest transaction was reported on 14 August 2026 (Sale). Among the most active insiders: 李志刚. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
美迪西 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on developing innovative solutions for the pharmaceutical industry.